Back to search

United Kingdom· GB-APID-45538811000001104

Lactulose 3.1-3.7g/5ml oral solution

A lactulose product containing lactulose, registered in United Kingdom by Numark Ltd. The same ATC class is registered in 16 of our 19 countries.

ATC A06AD11

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedLactulose 3.1-3.7g/5ml oral solutionATCA06AD11REGISTER NO.GB-APID-4553881100000…PACKS LISTED2CHECKEDSeptember 13, 2026

Where it is registered

Lactulose is registered in 16 of 19 countries.

Countries holding a registration under ATC A06AD11 (lactulose), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 8 of them publish a price we can compare per daily dose

Lactulose · ATC A06AD11

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Lactulose
Manufacturer
Numark Ltd
Country
United Kingdom (GB)
ATC code
A06AD11
ATC class
Lactulose
Defined daily dose
12.5 g, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 2

  • gtin
    5010441015872
  • gtin
    5010441015889

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

657 interactions on record for lactulose.

Graded by severity as the source publishes them — 263 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Lactulose · interactions on record

657 records

  • 263 moderate
  • 18 minor
  • 376 info

Most severe, free to view

  • CisaprideA03FA02moderate
  • OndansetronA04AA01moderate
  • GranisetronA04AA02moderate
  • DolasetronA04AA04moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Lactulose in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lactulose products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Duphalac Fruit, Lactulose Genericon
  • Belgium · Bifiteral, Duphalac
  • Bulgaria · Дуфалак, Лактулакс
  • Cyprus · Duphalac
  • Czechia · Duphalac, Lactulosa Biomedica
  • Germany · Bifiteral, Bifiteral Mit Pflaumenaroma
  • Denmark · Lactulose Orifarm, Medilax
  • Estonia · Duphalac, Duphalac Fruit
  • Spain · Duphalac, Lactulosa Lainco
  • Finland · Duphalac, Duphalac Fruit
  • France · Duphalac, Lactulose Arrow
  • Greece · Duphafruit, Duphalac
  • Croatia · Portalak, Portalak Efekt
  • Ireland · Brillphalac, Lactecon
  • Iceland · Medilax
  • Italy · Duphalac, Epalfen Eps
  • Lithuania · Duphalac, Duphalac Fruit
  • Luxembourg · Bifiteral, Duphalac
  • Latvia · Duphalac Fruit, Lactulose Mip
  • Malta · Duphalac, Lactulose
  • Netherlands · Duphalac, Duphalac Fruit
  • Norway · Duphalac, Duphalac Med Fruktsmak
  • Poland · Duphalac, Duphalac Fruit
  • Portugal · Duphalac, Duphalac Ameixa
  • Romania · Duphalac Fruit, Lactecon
  • Sweden · Duphalac, Laktulos Cooper
  • Slovenia · Prorektal
  • Slovakia · Duphalac, Lactecon

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ea47f754-f3c3-4e6a-8b68-e239b8a4d2a3
GET /v1/drugs/ea47f754-f3c3-4e6a-8b68-e239b8a4d2a3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "45538811000001104",
  "desc": "Lactulose 3.1-3.7g/5ml oral solution (Numark Ltd)",
  "form": "Oral solution",
  "vpid": "42354411000001105",
  "source": "dmd",
  "vtm_id": "776464008",
  "strength": "680 mg",
  "substance": "Lactulose",
  "ingredient": "Lactulose",
  "supplier_code": "3147301000001108"
}

See everything about lactulose.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.